Chancellor Rachel Reeves Intends Specific Measures on Bills in Upcoming Financial Plan
Treasury head Rachel Reeves has stated she is planning "focused action to deal with cost of living issues" in the upcoming Budget.
During an interview with media outlets, she stated that reducing inflation is a shared task of both the government and the Bank of England.
The United Kingdom's inflation rate is expected to be the most elevated among the G7 developed nations this year and the following year.
Potential Energy Cost Measures
Reports indicate the government could take action to reduce energy bills, for instance by slashing the current 5% level of value-added tax applied on energy supplies.
An additional option is to cut some of the government charges presently included in household expenses.
Budgetary Limitations and Analyst Predictions
The government will obtain the latest draft from the official forecaster, the OBR, on Monday, which will clarify how much room there is for these actions.
The consensus from most analysts is that the Chancellor will have to introduce higher taxes or spending cuts in order to meet her declared debt limits.
Previously on the same day, calculations indicated there was a £22 billion gap for the chancellor to fill, which is at the more modest range of forecasts.
"There's a joint responsibility between the Bank of England and the administration to bear down further on some of the drivers of price increases," the Chancellor informed reporters in the US capital, at the conferences of the International Monetary Fund and World Bank.
Tax Pledges and International Issues
While a great deal of the attention has been on likely tax increases, the chancellor said the most recent data from the fiscal watchdog had not altered her pledge to campaign commitments not to raise rates on income tax, VAT or social security contributions.
She attributed an "unpredictable world" with rising geopolitical and commercial concerns for the fiscal revenue measures, probably to be targeted on those "with the broadest shoulders."
International Trade Tensions
Referring to apprehensions about the United Kingdom's economic relations with China she said: "The UK's security interests always are paramount."
Last week's statement by China to increase trade restrictions on rare earths and other materials that are crucial for advanced tech manufacturing led American leader the US President to threaten an further 100% tariff on goods from China, raising the possibility of an full-scale commercial conflict between the two economic giants.
The American finance chief described the Chinese decision "commercial pressure" and "a global supply chain power grab."
Asked about considering the US offer to join its dispute with China, the Chancellor said she was "deeply worried" by Chinese measures and urged the Chinese government "not to put up barriers and restrict access."
She said the move was "damaging for the global economy and generates additional challenges."
"In my view there are sectors where we must challenge China, but there are also important opportunities to trade with China's economy, including financial services and other areas of the economic system. We've got to achieve that balance appropriate."
The chancellor also confirmed she was collaborating with G7 counterparts "regarding our own essential resources plan, so that we are less reliant."
NHS Medicine Costs and Funding
Reeves also acknowledged that the price the NHS pays for pharmaceuticals could go up as a consequence of current talks with the Trump administration and its drugs companies, in exchange for lower tariffs and funding.
Some of the biggest global drug companies have said in recent statements that they are either halting or canceling operations in the UK, with several attributing the modest returns they are receiving.
Recently, the Science Minister said the price the health service spends on medicines would need to go up to stop companies and drug research funding departing from the UK.
Reeves stated to the BBC: "We have seen due to the pricing regime, that medical research, new drugs have not been offered in the UK in the manner that they are in other European countries."
"Our aim is to ensure that individuals getting care from the National Health Service are can receive the best critical medicines in the globe. And so we are examining these issues, and... looking to attract more funding into the UK."